Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection.

Documenti analoghi

• Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children
  di: Mueller, Brigitta U., et al.
  Pubblicazione: (1998)
• Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
  di: Aweeka, F, et al.
  Pubblicazione: (1989)
• Pharmacokinetics of the Protease Inhibitor KNI-272 in Plasma and Cerebrospinal Fluid in Nonhuman Primates after Intravenous Dosing and in Human Immunodeficiency Virus-Infected Children after Intravenous and Oral Dosing
  di: Mueller, Brigitta U., et al.
  Pubblicazione: (1998)
• Penetration of foscarnet into cerebrospinal fluid of AIDS patients.
  di: Raffi, F, et al.
  Pubblicazione: (1993)
• Pharmacokinetics and Absolute Bioavailability of Oral Foscarnet in Human Immunodeficiency Virus-Seropositive Patients
  di: Noormohamed, Faruq H., et al.
  Pubblicazione: (1998)